G

Glycovaxyn AG

50 employees

GlycoVaxyn develops and manufactures biological conjugation vaccines against bacterial infections utilizing recombinant DNA technology.

Basic info

Industry

hospitals and health care

Sectors

Biotechnology
Pharmaceutical
Manufacturing

Date founded

2004

Funding rounds raised

Total raised

$21M

from 7 investors over 7 rounds

G

Glycovaxyn AG raised $21M on March 5, 2009

Investors: Sofinnova Partners, Edmond de Rothschild and Index Ventures

G

Glycovaxyn AG raised $9.5M on July 16, 2007

Investors: Index Ventures and Sofinnova Partners

G

Glycovaxyn AG raised undisclosed on July 6, 2006

Investors: Sofinnova Partners and Index Ventures

FAQ